Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?
- PMID: 29449263
- PMCID: PMC5964406
Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?
Abstract
Objective: To describe recent trends and patterns in methadone maintenance treatment (MMT) practice regionally and over time in the province of Ontario.
Design: Population-based descriptive study using health administrative data between September 1, 2011, and December 31, 2014.
Setting: Ontario.
Participants: All active MMT-prescribing physicians and patients receiving MMT in the study period.
Main outcome measures: Characteristics of MMT-prescribing physicians, including age, sex, specialty type, practice region, and practice volume; characteristics of patients receiving MMT, including age, sex, neighbourhood income, and region of residence.
Results: Between September 1, 2011, and December 31, 2014, the number of MMT-prescribing physicians and patients who received MMT increased by 26% and 42%, respectively. In 2014, there was a total of 312 MMT-prescribing physicians and 49 703 patients receiving MMT. In 2014 and on a per capita basis, patients receiving MMT were more prevalent in rural regions; and within rural regions, there were disproportionately large numbers of young female MMT patients residing in low-income neighbourhoods.
Conclusion: The number of physicians prescribing MMT and patients receiving MMT has increased substantially between 2011 and 2014, with the largest per capita distribution occurring in rural regions and involving young adults. While availability of and access to MMT has improved considerably from before 2000 to levels of high use, these developments are likely influenced by recent trends in the proliferation of prescription opioid misuse across general populations.
Objectif: Décrire les tendances et les modèles récents dans l’utilisation du TMM en Ontario, selon les régions et les périodes.
Type d’étude: Étude descriptive démographique à l’aide de données administratives sanitaires portant sur la période allant du 1er septembre 2011 au 31 décembre 2014.
Contexte: L’Ontario.
Participants: Tous les médecins actifs ayant prescrit des TMM et les patients auxquels ils l’ont prescrit au cours de la période à l’étude.
Principaux paramètres à l’étude: Les caractéristiques des médecins prescrivant les TMM, y compris l’âge, le sexe, la spécialité, la région de pratique et le volume de la clientèle; les caractéristiques des patients recevant le TMM, y compris l’âge, le sexe, le revenu des familles du voisinage et la région habitée.
Résultats: Entre le 1er septembre 2011 et le 31 décembre 2014, le nombre des médecins qui prescrivaient le TMM et celui des patients qui recevaient ce traitement ont augmenté respectivement de 26 % et 42 %. En 2014, un total de 312 médecins prescrivaient le TMM, et 49 703 patients recevaient ce traitement. En 2014, au prorata de la population locale, les patients ainsi traités étaient plus nombreux dans les régions rurales, et dans ces régions, il y avait un nombre disproportionné de jeunes femmes traitées qui habitaient des quartiers à faible revenu.
Conclusion: Le nombre de médecins prescrivant le TMM et de patients recevant ce traitement a augmenté de façon importante, la plus forte distribution per capita étant observée dans les régions rurales, particulièrement chez les jeunes adultes. Bien que la disponibilité et l’accès au TMM se soient améliorés considérablement depuis 2000, pour atteindre un taux d’utilisation élevé, ces changements sont probablement influencés par les récentes tendances dans la prolifération d’un mauvais usage des opioïdes d’ordonnance au sein de la population générale.
Copyright© the College of Family Physicians of Canada.
Figures


Similar articles
-
High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort study.Am J Addict. 2014 May-Jun;23(3):257-64. doi: 10.1111/j.1521-0391.2014.12091.x. Am J Addict. 2014. PMID: 24724883 Free PMC article.
-
Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada.J Addict Med. 2015 Nov-Dec;9(6):440-6. doi: 10.1097/ADM.0000000000000156. J Addict Med. 2015. PMID: 26484843 Free PMC article.
-
Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.Drug Alcohol Depend. 2017 Aug 1;177:315-321. doi: 10.1016/j.drugalcdep.2017.05.002. Epub 2017 Jul 19. Drug Alcohol Depend. 2017. PMID: 28733101
-
Medication-assisted treatment with methadone: assessing the evidence.Psychiatr Serv. 2014 Feb 1;65(2):146-57. doi: 10.1176/appi.ps.201300235. Psychiatr Serv. 2014. PMID: 24248468 Review.
-
The role of the Chinese police in methadone maintenance therapy: a literature review.Int J Drug Policy. 2013 Nov;24(6):e25-34. doi: 10.1016/j.drugpo.2013.03.010. Epub 2013 Apr 25. Int J Drug Policy. 2013. PMID: 23623719 Review.
Cited by
-
Treatment of prescription opioid disorders in Canada: looking at the 'other epidemic'?Subst Abuse Treat Prev Policy. 2016 Mar 8;11:12. doi: 10.1186/s13011-016-0055-4. Subst Abuse Treat Prev Policy. 2016. PMID: 26952717 Free PMC article.
-
Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder.JAMA Netw Open. 2022 Apr 1;5(4):e227028. doi: 10.1001/jamanetworkopen.2022.7028. JAMA Netw Open. 2022. PMID: 35438757 Free PMC article.
-
Methadone Prescribing Regulation for Opioid Use Disorder in Canada: Evidence for an East-West Policy Divide.Healthc Policy. 2024 Feb;19(3):49-61. doi: 10.12927/hcpol.2024.27228. Healthc Policy. 2024. PMID: 38721734 Free PMC article.
-
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada.JAMA Netw Open. 2021 Jul 1;4(7):e2118223. doi: 10.1001/jamanetworkopen.2021.18223. JAMA Netw Open. 2021. PMID: 34297070 Free PMC article.
-
Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in Northern Ontario, Canada.PLoS One. 2019 Dec 5;14(12):e0225548. doi: 10.1371/journal.pone.0225548. eCollection 2019. PLoS One. 2019. PMID: 31805082 Free PMC article.
References
-
- Advisory Committee on Population Health . Reducing the harm associated with injection drug use in Canada. Ottawa, ON: Health Canada; 2001. Available from: http://publications.gc.ca/collections/Collection/H39-589-2001E.pdf. Accessed 2018 Jan 11.
-
- Millar JS. HIV, hepatitis, and injection drug use in British Columbia—pay now or pay later? Victoria, BC: BC Ministry of Health; 1998.
-
- Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59–65. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical